Back to Journals » Infection and Drug Resistance » Volume 13

Characterization of a Novel NDM-5-Harboring Plasmid from a Carbapenem-Resistant Escherichia coli Isolate from China

Authors Yin D, Lin Y, Li Z, Ma H, Lu L, Wang K, Yang L, Du X, Li P, Qi K, Song H

Received 20 August 2020

Accepted for publication 15 October 2020

Published 2 November 2020 Volume 2020:13 Pages 3929—3935

DOI https://doi.org/10.2147/IDR.S277997

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Suresh Antony

Download Article [PDF] 

Dongdong Yin,1,2,* Yanfeng Lin,1,3,* Zhonghong Li,1,4,* Hui Ma,5,* Lanfen Lu,6 Kaiying Wang,1,3 Lang Yang,1,3 Xinying Du,1 Peng Li,1 Kezong Qi,2 Hongbin Song1,*

1Center for Disease Control and Prevention of PLA, Beijing, People’s Republic of China; 2Anhui Province Key Laboratory of Veterinary Pathobiology and Disease Control College of Animal Science and Technology, Anhui Agricultural University, Hefei, People’s Republic of China; 3Institute for Disease Control and Prevention, AMMS, Beijing, People’s Republic of China; 4College of Environmental and Chemical Engineering, Nanchang Hangkong University, Nanchang, People’s Republic of China; 5The Sixth Medical Center of PLA General Hospital, Beijing, People’s Republic of China; 6Department of Laboratory Diagnosis, Sun Yat-Sen University Affiliated Zhongshan Hospital, Zhongshan, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Peng Li; Kezong Qi Email [email protected]; [email protected]

Background: A carbapenem-resistant Escherichia coli (sequence type 5415) strain was isolated from a male patient through routine surveillance in 2018 in Guangzhou, China.
Materials and Methods: Bacteria were isolated from a sputum culture and identified by using the Vitek 2 compact system. The blaNDM-5 gene was amplified and confirmed by sequencing. Antimicrobial susceptibility testing was determined by a Vitek 2 compact system. The blaNDM-5 gene was located by Southern blotting. Whole-genome sequencing was carried out using both Illumina MiSeq and Oxford Nanopore MinION.
Results: S1-PFGE and Southern blotting showed that the blaNDM-5 gene was located on a novel 66-kb IncFII [F2:A-:B-] plasmid. Conjugation assays revealed that the blaNDM-5-bearing plasmid was self-transferrable. Genomic sequencing and comparative analysis suggested that plasmid p2947-NDM5 likely originated from a combination of an IncFII-type backbone and the blaNDM-5 flanking genetic elements.
Conclusion: This is the first report of an ST5414 E. coli strain expressing an NDM-5 β-lactamase. This study highlights the genetic complexity of blaNDM-5 carrying plasmids and the urgent need for continuous active monitoring.

Keywords: Escherichia coli, ST5415, NDM-5, IncFII, carbapenem resistant

Introduction

Carbapenemase-producing Enterobacteriaceae (CPE) constitute a public health problem in terms of both hospital- and community-acquired infections.1 Since the identification of NDM-1 in a Swedish traveler returning from India in 2009,2 NDM enzymes have received special attention due to their rapid global spread and frequent association with other resistance genes. NDM-5 was first identified in an Escherichia coli strain isolated from a patient who had been hospitalized in India.3 Since then, NDM-5 has been detected in different countries around the world.4–8 The amino acid sequence of NDM-5 differs from that of NDM-1 at positions 88 (Val→Leu) and 154 (Met→Leu), which confer a high level of hydrolytic activity against carbapenems.3 The rapid evolution and dissemination of NDM-5 represent a crucial challenge for clinical treatments.

Extraintestinal E. coli is a relatively common pathogen causing community and infections among Enterobacteriaceae in China. The acquisition of NDM is a great concern since it would greatly limit the treatments for E. coli that frequently carry multiple resistance determinants. Identifying clones or plasmids with blaNDM genes is important for understanding the epidemiology of resistance and controlling the spread of NDM in communities and healthcare systems.9,10

In this study, we report the emergence of the NDM-5-producing E. coli strain ST5414 in China and characterized a novel plasmid carrying the blaNDM-5 gene using Illumina and Nanopore sequencing platforms.

Materials and Methods

Identification of the E. coli Strain Carrying blaNDM

A carbapenem-resistant strain, ECO2947, was recovered from a sputum culture of a patient through routine surveillance in 2018 in Guangzhou, China. The species of strain ECO2947 was identified by the Vitek 2 compact system (bioMérieux, France). The blaNDM gene was detected by PCR and sequencing with primers blaNDM-F (5′-GGCGGAATGGCTCATCACGA-3′) and blaNDM-R (5′-CGCAACACAGCCTG ACTTTC-3′).11,12 Ethics committee approval was obtained from the institutional review board of Sun Yat-Sen University Affiliated Zhongshan Hospital for these isolates, and verbal informed consent from patient was also accepted and approved by Sun Yat-Sen University Affiliated Zhongshan Hospital. All experiments were conducted in accordance with relevant regulations and approved by the Chinese PLA Center for Disease Control and Prevention.

S1-PFGE, Southern Blotting and Conjugation

Bacterial genomic DNA from strain ECO2947 was prepared in agarose plugs and digested with the S1 endonuclease (Takara, Dalian, China). DNA fragments were separated by pulsed-field gel electrophoresis (PFGE) through a CHEF-DR III system (Bio-Rad, Hercules, USA). The conditions of the PFGE run were 6.0 V/cm gradient, 120° angle, and 7- to 26-second pulse times for 15 h. The plasmid DNA was transferred to a positively charged nylon membrane (Solabio, China) and hybridized with the digoxigenin-labeled specific probe to blaNDM-5. The experiment was performed according to the manufacturer’s manual of the DIG High Prime DNA Labeling and Detection Start Kit I (Cat. No: 11,745,832,910, Roche).

Conjugation experiments were performed by broth and filter mating using strain ECO2947 as the donor and azide-resistant E. coli J53 as the recipient. Strains ECO2947 and J53 were mixed (ratio of 1:3) in Luria‐Bertani (LB) broth, which was used to make LB agar plates, and incubated for 18 h . The mixture was spread on a selective MacConkey agar plate containing meropenem (4 μg/mL) and sodium azide (150 μg/mL) to select transconjugants. Horizontal transferability of drug resistance was evaluated by antimicrobial susceptibility testing, and the corresponding transconjugants were confirmed by S1-PFGE.

Antimicrobial Susceptibility Testing

The minimal inhibitory concentrations (MICs) of amikacin, ampicillin, sulbactam/ampicillin, aztreonam, furadantin, ciprofloxacin, piperacillin/tazobactam, gentamicin, cefepime, ceftriaxone, ceftazidime, cefotetan, cefamedin, tobramycin, imipenem and levofloxacin were determined by a Vitek 2 compact system (bioMérieux, France) following the manufacturer’s instructions. The results were interpreted following the guidelines of the Clinical and Laboratory Standards Institute (CLSI).13

Whole Sequencing and Analysis

Genomic DNA was extracted using a High Pure PCR Template Preparation Kit (Roche, Basel, Switzerland). Sequencing was carried out using both Illumina MiSeq and Oxford Nanopore MinION. The de novo hybrid assembly of short Illumina reads and long MinION reads was performed using Unicycler v0.4.814 with the conservative mode. Complete circular contigs were corrected using Pilon with Illumina reads for several rounds until no change was detected. Genome sequences were annotated using the RAST server.15 The sequence type was determined through the MLST web server.16 Virulence genes and plasmid types were identified using VirulenceFinder, PlasmidFinder and pMLST.17

Nucleotide Sequence Accession Number

The complete sequences of the chromosome of strain ECO2947, plasmid p2947-D and p2947-NDM5 have been deposited in GenBank under accession numbers CP046259, CP046260 and CP046261, respectively.

Results

Bacterial Identification and Susceptibility Testing

Strain ECO2947 was identified as E. coli using the Vitek 2 compact system and confirmed by 16S rRNA sequencing. The MIC values of the tested antimicrobials revealed that E. coli ECO2947 exhibited resistance to nearly all tested β-lactam antibiotics, including ampicillin, sulbactam/ampicillin, piperacillin/tazobactam, ceftriaxone, ceftazidime, cefepime, cefamedin and imipenem, with the exception of aztreonam (Table 1). PCR amplification and sequencing confirmed the presence of blaNDM-5.

Table 1 Antibiotic Susceptibilities of E. coli ECO2947 and the E. coli J53 Transconjugants

Microbiological and Genomic Features of E. coli ECO2947

S1 PFGE showed that E. coli ECO2947 contained two different plasmids (~66 kb and ~108 kb) (Figure 1). Southern blotting revealed that the blaNDM-5 gene was located on the ~66 kb plasmid (named p2947-NDM5), which was transferred to E. coli J53 at a frequency of 1.63×10−2 transconjugants per donor cell.

Figure 1 S1-PFGE pattern for strain ECO2947 and southern blotting for the blaNDM-5 gene. Lanes: Marker, Salmonella serotype Braenderup strain H9812 as the size standard; 1, PFGE result for S1-digested plasmid DNA of strain ECO2947; 2, Southern blotting with the probe specific to blaNDM-5; 3, PFGE patterns for S1-digested plasmid DNA of E. coli transconjugants J53.

The transconjugants acquired resistance to ampicillin, ceftriaxone, sulbactam/ampicillin, piperacillin/tazobactam, ceftazidime, cefamedin, and imipenem (Table 1), and the MIC values of carbapenems in the transconjugants were considerably increased compared with those of the recipient strain E. coli J53.

E. coli ECO2947 was further subjected to sequencing using both MiSeq and MinION sequencing. Genomic analysis revealed that strain E. coli ECO2947 belonged to a novel sequence type ST5414 and had a 4,884,967 bp chromosome and two plasmids. Twelve virulence factors were found in the genome: single copies of eae (intimin), espA (type III secretion system), espB (secreted protein B), espF (type III secretion system), iss (increased serum survival), lpfA (long polar fimbriae), nleA (non-LEE encoded effector A), nleB (non-LEE encoded effector B), nleC (non-LEE encoded effector C), tir (translocated intimin receptor protein) and two copies of gad (glutamate decarboxylase). A screening for acquired resistance determinants found that the chromosome only possessed the resistance gene mdf(A) (prototypic secondary multidrug transporter), while the plasmid p2947-NDM5 carried only blaNDM-5, and the other plasmid (named p2947-D) carried multiple resistance genes, including sul2 (sulfonamide resistance), qnrS1 (fluoroquinolone resistance), aph(3”)-Ib and aph(6)-Id (aminoglycoside resistance).

Characterization of the Novel blaNDM-5-Harboring Plasmid

The blaNDM-5-harboring plasmid p2947-NDM5 belonged to the incompatibility type IncFII [F2:A-:B-] with a length of 66,053 bp, an average G + C content of 52.41% and 94 predicted coding sequences. p2947-NDM5 had a 61-kb backbone and a 5-kb multidrug resistance (MDR) region. A BLAST search revealed that p2947-NDM5 was highly similar to plasmid p974-NDM of E. coli strain 974 (accession number: MG825370.1) (99% coverage and 99.66% identity), plasmid unnamed4 of Klebsiella pneumoniae strain 4743 (accession number: CP033629.1) (93% coverage and 100% identity, referred to as p4743) and the plasmid of Salmonella enterica subsp. enterica serovar Derby strain 75 (accession number: MK191836.1) (92% coverage and 99.97% identity, referred to as p75). The four plasmids have almost identical backbones and contain a set of core genes responsible for plasmid replication (repA), conjugation/T4SS (tra and trb genes), stability (stdB) and segregation (parM) (Figure 2A). However, p2947-NDM5 had quite different MDR regions from these similar plasmids. In p2947-NDM5, blaNDM-5—together with bleMBL (mediating bleomycin resistance), trpF (encoding the phosphoribosylanthranilate isomerase), tat (encoding tat twin-arginine translocation pathway signal sequence domain protein) and ctuA1 (encoding periplasmic divalent cation tolerance protein) was bracketed by IS5 and IS26, while p974-NDM had the blaNDM-1 gene instead and an additional region composed of IS26, ISKox3, resolvase, Tn2 transposon, IS3000 and ΔISAba125. Plasmids p75 and p4743 had quite different resistance genes and genetic contexts. Both p75 and p4743 had two copies of IS26 at each end; the former was composed of IS26-IS903-BtuB-tnpR Tn3-IS26, while the latter was composed of IS26-intl1-IS26blaTEM-WbuC-blaCTX-M-15-IS26 (Figure 2B).

Figure 2 Plasmid analysis of p2947-NDM5. (A) Genetic structure comparison of p2947-NDM5, CP033629.1), MK191836.1) and MG825370.1). (B) Comparative analysis of MDR regions. (C) Comparative analysis of the genetic contexts of blaNDM-5 in plasmids reported in this study and previously described.

Comparative analysis revealed that the genetic context of blaNDM-5 (∼5100 bp) in p2947-NDM5 was nearly identical to those previously reported in pGZ3-NDM5 (accession number: CP017981.1) (100% coverage and 100% identity), pNDM-HK3774 (accession number: MI1234502.1) (100% coverage and 100% identity), pHNAH699 (accession number: MH286952.1) (100% coverage and 100% identity) and pP855-NDM5 (accession number: MF547508.1) (100% coverage and 99.98% identity) (Figure 2C). However, compared with the above reference plasmids, p2947-NDM5 lacked IS3000.

Discussion

Due to the intrinsic and acquired resistance of E. coli, this bacterium constitutes a serious clinical threat that limits the choice of treatment. Most reports have indicated a high ST diversity for blaNDM-5-positive E. coli.4,18,19 The MLST analysis revealed that E. coli ECO2947 belongs to ST5414, which is unlike the ST types of NDM-5-producing E. coli ST167 (China),18 ST540 (Japan),20 ST648 (Australia), ST648 (UK)3 and ST648 (India). This appears to be the first report of an ST5414 E. coli strain expressing an NDM-5 β-lactamase. This is a worrying development, as it demonstrates the further spread of blaNDM-5 among different ST types of E. coli, and the transfer frequency of p2947-NDM5 demonstrated its great potential to transfer across species.

IncFII-type plasmids are a group of plasmid families with similar replicons and transfer regions,21 which are spread among Enterobacteriaceae in humans and animals worldwide.6,22,23 Although the IncFII-type plasmids are narrow host plasmids, the plasmid can adapt well to E.coli, are easy to conjugate and transfer, and facilitates the spread of resistance genes.24–26 Horizontal gene transfer also promotes the widespread dissemination of blaNDM in Enterobacterales.27 In this study, two of the three plasmids highly similar to p2947-NDM5 were from animals. Klebsiella pneumoniae strain 4743 was isolated from humans in Italy, the Salmonella enterica subsp. enterica serovar Derby strain was isolated from swine in the United States, and the E. coli strain 974 was isolated from a pig in Hong Kong. Additionally, the genetic context of blaNDM-5 of p2947-NDM5 has also been found on different types of plasmids and in different species, and a conjugation assay revealed that p2947-NDM5 was self-transferrable. From this, we speculated that p2947-NDM5 was the genetic context of blaNDM-5, which had been inserted into the IncFII [F2:A-:B-] plasmid backbone during transmission, and p2947-NDM5 has a potential risk of spread across species. Therefore, the association of IncFII plasmids and blaNDM variants and the epidemiology of IncFII plasmids in Enterobacteriaceae warrant more studies.

Conclusion

In summary, we identified a blaNDM-5-positive E. coli strain, ST5414, for the first time. The blaNDM-5 gene was located on a novel self-transferrable IncFII-type plasmid. Our study highlights the potential spread of carbapenem-resistant plasmids among Enterobacteriaceae. Further research is necessary to take urgent and effective surveillance measures and to control the spread of the blaNDM-5-carrying IncFII plasmids.

Author Contributions

All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for content; gave final approval of the version to be published and agreed to be accountable for all aspects of the work.

Funding

The study was supported by grants from the National Science and Technology Major Project (no. 2018ZX10201001-003 and no. 2018ZX10712001-002-002), the Beijing Natural Science Foundation (no. 5172029) and the Beijing Nova Program (no. Z181100006218110).

Disclosure

The authors report no conflicts of interest in this work.

References

1. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.003

2. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–5054. doi:10.1128/AAC.00774-09

3. Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother. 2011;55(12):5952–5954. doi:10.1128/AAC.05108-11

4. Sassi A, Loucif L, Gupta SK, et al. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother. 2014;58(9):5606–5608. doi:10.1128/AAC.02818-13

5. Nakano R, Nakano A, Hikosaka K, et al. First report of metallo-β-lactamase NDM-5-producing Escherichia coli in Japan. Antimicrob Agents Chemother. 2014;58(12):7611–7612. doi:10.1128/AAC.04265-14

6. Pitart C, Sole M, Roca I, et al. Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain. Antimicrob Agents Chemother. 2015;59(1):659–662. doi:10.1128/AAC.04040-14

7. de Man TJ, Perry KA, Avillan JJ, et al. Draft genome sequence of a New Delhi metallo-β-lactamase-5 (NDM-5)-producing multidrug-resistant Escherichia coli isolate. Genome Announc. 2015;3(2). doi:10.1128/genomeA.00017-15

8. Wailan AM, Paterson DL, Caffery M, et al. Draft genome sequence of NDM-5-producing Escherichia coli sequence type 648 and genetic context of blaNDM-5 in Australia. Genome Announc. 2015;3(2). doi:10.1128/genomeA.00194-15

9. Giufre M, Errico G, Accogli M, et al. Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy. Int J Antimicrob Agents. 2018;52(1):76–81. doi:10.1016/j.ijantimicag.2018.02.020

10. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in gram-negative bacteria. Biomed Res Int. 2014;2014:249856. doi:10.1155/2014/249856

11. Frank JA, Reich CI, Sharma S, et al. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol. 2008;74:2461–2470. doi:10.1128/AEM.02272-07

12. Zong Z, Zhang X. blaNDM-1-carrying acinetobacter johnsonii detected in hospital sewage. J Antimicrob Chemother. 2013;68(5):1007–1010. doi:10.1093/jac/dks505

13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Eighth Informational Supplement. M100-S28. Wayne, PA, USA: CLSI; 2018.

14. Wick RR, Judd LM, Gorrie CL, et al. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595. doi:10.1371/journal.pcbi.1005595

15. Aziz RK, Bartels D, Best AA, et al. The RAST server: rapid annotations using subsystems technology. BMC Genom. 2008;9(1):75. doi:10.1186/1471-2164-9-75

16. Larsen MV, Cosentino S, Rasmussen S, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50(4):1355–1361. doi:10.1128/JCM.06094-11

17. Carattoli A, Zankari E, Garcia-Fernandez A, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58:3895–3903. doi:10.1128/AAC.02412-14

18. Yang P, Xie Y, Feng P, et al. blaNDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrob Agents Chemother. 2014;58(12):7548–7552. doi:10.1128/AAC.03911-14

19. Zhang F, Xie L, Wang X, et al. Further spread of blaNDM-5 in Enterobacteriaceae via IncX3 plasmids in Shanghai, China. Front Microbiol. 2016;7:424. doi:10.3389/fmicb.2016.00424

20. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect. 2014;44(2):51–56. doi:10.1016/j.medmal.2013.11.007

21. Laura V, Aurora G-F, Daniela F, et al. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother. 2010:65(12):2518–2529.

22. Chen L, Chavda KD, Melano RG, et al. Complete sequence of a blaKPC-2 -harboring IncFIIK1 plasmid from a Klebsiella pneumoniae sequence type 258 strain. Antimicrob Agents Chemother. 2013;57(3):1542–1545. doi:10.1128/AAC.02332-12

23. Cheng VC, Wong SC, Ho PL, et al. Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China. Emerg Microbes Infect. 2015;4(1):e8. doi:10.1038/emi.2015.8

24. Ho PL, Chan J, Lo WU, et al. Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol. 2013;114(3):695–702. doi:10.1111/jam.12099

25. Lo WU, Chow KH, Law PY, et al. Highly conjugative IncX4 plasmids carrying bla CTX-M in Escherichia coli from humans and food animals. J Med Microbiol. 2014;63(6):835–840. doi:10.1099/jmm.0.074021-0

26. Ho PL, Lo WU, Yeung MK, et al. Dissemination of pHK01-like incompatibility group IncFII plasmids encoding CTX-M-14 in Escherichia coli from human and animal sources. Vet Microbiol. 2012;158(1–2):172–179. doi:10.1016/j.vetmic.2012.02.004

27. Guo X, Rao Y, Guo L, et al. Detection and genomic characterization of a Morganella morganii isolate from China that produces NDM-5. Front Microbiol. 2019;10:1156. doi:10.3389/fmicb.2019.01156

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]